SEC Form 4 · accession 0001179110-16-019451
INTERMOLECULAR INC · IMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Irwin Federman
Director
Period of report
Feb 12, 2016
Accepted (ET)
Feb 17, 2016 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311241
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 per share | Feb 12, 2016 | P | 400 | $2.12 | A | 245,681 | D | |
| Common Stock, $0.001 per share | Feb 16, 2016 | P | 4,316 | $2.12 | A | 249,997 | D | |
| Common Stock, $0.001 per shareF1 | holding | — | — | — | 4,280,779 | I | Directly owned by USVP IX |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Presidio Management Group IX, LLC ("PMG IX") is the general partner of US Venture Partners IX, L.P. ("USVP IX") and Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, the managing members of PMG IX, may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.
Remarks
Exhibit List:Exhibit 24 - Power of Attorney